Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | BLM | P54132 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.38 |
| ▸ | RECQL | P46063 | 3/20 | 0.38 |
| ▸ | AURKA | O14965 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL299115 | 0.77 | ALDH1A1 (0.47) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL594152 | 0.77 | CDC25B (0.47) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL28758918 | 0.74 | ALDH1A1 (0.45) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL28498261 | 0.74 | CDC25B (0.45) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL11664840 | 0.71 | — | — | |
| SCHEMBL6618539 | 0.65 | MEN1 (0.38) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL5612308 | 0.65 | HPGD (0.38) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL16994960 | 0.65 | AURKA (0.38) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL1697785 | 0.65 | AURKA (0.38) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL2687051 | 0.65 | AURKA (0.38) | MEN1ALDH1A1MAPTKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3279663-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2021-07-28 | — | — | EP | claimed |
| EP-2001496-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2017-05-31 | — | — | EP | claimed |
| US-20120014953-A1 | TREATING AND EVALUATING INFLAMMATORY DISORDERS | BIOGEN IDEC MA INC. (US) | 2012-01-19 | — | — | US | claimed |
| EP-1885388-A4 | TREATING AND EVALUATING INFLAMMATORY DISORDERS | BIOGEN IDEC INC (US) | 2009-09-02 | — | — | EP | claimed |
| US-7571055-B2 | Diagnosing autoimmune diseases via variances in gene expression patterns in peripheral blood mononuclear cells, determine interferon biomarkers concentration | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2009-08-04 | — | — | US | claimed |
| US-20080187544-A1 | TREATING AND EVALUATING INFLAMMATORY DISORDERS | BIOGEN IDEC MA INC. | 2008-08-07 | — | — | US | claimed |
| EP-1885388-A2 | TREATING AND EVALUATING INFLAMMATORY DISORDERS | Biogen Idec MA Inc. (US) | 2008-02-13 | — | — | EP | claimed |
| WO-2006122187-A2 | TREATING AND EVALUATING INFLAMMATORY DISORDERS | BIOGEN IDEC MA INC. (US) | 2006-11-16 | — | — | WO | claimed |
| US-20240156877-A1 | COMPOSITIONS AND USES THEREFOR | MELCARE MEDICAL PTY LTD (AU) | 2024-05-16 | — | — | US | disclosed |
| EP-4368178-A1 | COMPOSITIONS OF HONEY AND GLUCONIC ACID AND USES THEREFOR | Melcare Medical Pty Ltd (AU) | 2024-05-15 | — | — | EP | disclosed |
| CN-117940126-A | Treatment for cold-related periodic syndromes (CAPS) | 兹杜斯生命科学有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117858871-A | Treatment for neuroinflammatory disorders | 兹杜斯生命科学有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117157082-A | Composition for inhibiting cytokine production containing D-allose as active ingredient, and method for treating or preventing diseases associated with cytokine overproduction using the same | 国立大学法人香川大学 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023141679-A1 | DIMERS AND USES THEREFOR | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-08-03 | — | — | WO | disclosed |
| WO-2001001976-A2 | COMPOSITION COMPRISING AN EXTRACT OF PERNA CANALICULUS, METHYLSULFONYLMETHANE AND GLUCOSAMINE | FOODSCIENCE CORPORATION (US) | 2001-01-11 | — | — | WO | disclosed |
| WO-2000071140-A2 | METHODS AND COMPOSITIONS FOR MODULATING IMMUNE RESPONSE AND FOR THE TREATMENT OF INFLAMMATORY DISEASE | FOODSCIENCE CORPORATION (US) | 2000-11-30 | — | — | WO | disclosed |
| US-6090836-A | DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION | MERCK & CO., INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| CN-1188135-A | Liquid crystalline resin and molded product thereof | TORAY INDUSTRIES (JP) | 1998-07-22 | — | — | CN | disclosed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |